Compared to other cytokines such as interleukin-1 (IL-1) and tumor necrosis factor (TNF), anti-IL-6 therapy is more effective in improving serum lipoprotein levels in patients with rheumatoid arthritis (RA) (10). Here, IL6 is linked to rheumatoid arthritis.